Andrew R. Blight
2013
In 2013, Andrew R. Blight earned a total compensation of $1.5M as Chief Scientific Officer at Acorda Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,000 |
|---|---|
| Non-Equity Incentive Plan | $161,023 |
| Option Awards | $663,214 |
| Salary | $421,700 |
| Stock Awards | $229,973 |
| Other | $7,650 |
| Total | $1,484,560 |
Blight received $663.2K in option awards, accounting for 45% of the total pay in 2013.
Blight also received $1K in bonus, $161K in non-equity incentive plan, $421.7K in salary, $230K in stock awards and $7.7K in other compensation.
Rankings
In 2013, Andrew R. Blight's compensation ranked 4,980th out of 12,286 executives tracked by ExecPay. In other words, Blight earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,980 out of 12,286 | 60th |
Division Manufacturing | 1,715 out of 4,612 | 63rd |
Major group Chemicals And Allied Products | 491 out of 1,462 | 66th |
Industry group Drugs | 346 out of 1,156 | 70th |
Industry Biological Products, Except Diagnostic Substances | 53 out of 196 | 73rd |
Source: SEC filing on April 25, 2014.
Blight's colleagues
We found six more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2013
David Lawrence
Acorda Therapeutics